Member Info for ShearClass

Maqsood, for every buy there has to be a sell - we’ll see some huge delayed sells from yesterday after close today IMO. Nevertheless I completely agree that this will be huge over the coming weeks / months!

There has been more than a sniff of news Maqsood - clearly someone is selling, we’ll find out who soon but it must be a major holder to have held the price down here with around 8m shares bought yesterday & today. Link have to be favourites, but let’s see.

Once you start to see 800k buys popping up you know this is only going in one direction - that’s 0.7% of the company acquired in 1 trade!

Nobody cares about a Woodford overhang, the volume during the course of this week will be gigantic - I’d not be surprised if another II (Lombard or RG for example) buy the link stake, the potential value here is unreal.

In light of the current situation, huge media coverage & game changing potential that SNG0001 has, how can anyone come on here and post that “it’s only respiratory not a vaccine”, unbelievable.

This could save tens of thousands of lives by preventing people getting ill in the first place! Yes a vaccine will be great, but a drug like this could mean things can get back to normal far faster than expected.

Daily Mail;

www.dailymail.co.uk/news/article-8128835/amp/Coronavirus-sufferers-given-hope-researchers-Southampton-University.html

Daily Express :

www.express.co.uk/life-style/health/1257151/coronavirus-drug-scientists-UK-hospital-patients-new-treatments/amp

The Times :

https://www.thetimes.co.uk/edition/business/ergomed-and-synairgen-drug-firms-test-virus-therapies-bvcn70f5p

Sky News :

https://news.sky.com/story/coronavirus-new-treatment-for-critically-ill-patients-to-begin-as-soon-as-next-week-11959914

Guardian :

https://www.google.co.uk/amp/s/amp.theguardian.com/world/2020/mar/18/uk-coronavirus-patients-trial-experimental-lung-drug-synairgen-cure

New York Times :

https://www.nytimes.com/reuters/2020/03/18/world/europe/18reuters-health-coronavirus-synairgen.html

I’m sure there is more but truly epic coverage, I can only imagine the reaction if it works.

In the Times too!

https://www.thetimes.co.uk/edition/business/ergomed-and-synairgen-drug-firms-test-virus-therapies-bvcn70f5p

Truly unbelievable that the price finished 2% down! It’ll surely be a very different case today.

If their treatment works, this could become a billion pound + market cap overnight. £10 per share would do nicely!

Was it an interview on Sky or news item? This could rise 300% to £1 and still be ridiculously cheap!

@Achilles, you’d have to be unbelievably brazen to insider trade for £300k on a share with the average daily volume this has. It stands out like a sore thumb and I can’t believe anyone would be that stupid.

The 1.15m at 25p from yesterday is clearly a BUY. The highest price paid yesterday other than this trade was 24.4p. There is no evidence at all that it was sold today, that is pure speculation. Either way with the media coverage tonight the price is only going one way IMO, this is a potentially transformational treatment.

How on earth is this a £26m market cap?!?

From the website Pumped or Dumped - go
to full share search & enter SNG, you can see the time stamp (seeing LSE is still broken).

Very interesting late trade of 1,150,000 @ 25p time stamped at 2.54pm yesterday. The highest price paid yesterday was 24.4p, so this has to be a buy.

It may well explain the crazy share price behaviour today, as the MM’s were short of shares and had to drop the price to generate sales to fill this order.

The question is who bought 1% of the company the day before the announcement?!

Trade can be seen here;

hTTp://******************/data/show_trades.php?search=SNG&date=18-03-2020

Destitute, you keep mentioning the word pump, it is nothing of the sort! Read the comment below, in particular the last sentence. WORLD LEADING TRIAL. And that is from an objective third part professor. The sky is the limit here if the pilot is successful.

Professor Tom Wilkinson, Professor of Respiratory Medicine at the University of Southampton and Trial Chief Investigator, commented: "We are facing an unprecedented health challenge with COVID-19 which desperately requires the rapid development of new therapeutic strategies. There are a limited number of candidate new treatments available and so it is vital we can rapidly generate high quality evidence on the role of these in COVID-19 patients. The UK research delivery and regulatory teams have worked incredibly effectively to enable this world leading trial to achieve approvals so rapidly which has enabled our motivated and highly expert team of researchers to get this vital study running straight away."

Destitute, my bet would be that Link Fund solutions have used this mornings rise to start offloading their 21m holding and once this overhang clears the price will rocket.

Nothing else could explain the fall from 45p to 25p on news of a potential cure for Covid-19 in the current environment.

Let’s see what we get through in terms of delayed trades / TR1’s

Very silly in this market to sell for a £1700 loss, why didn’t you sell this morning at £1.40 if you were trading it? Also almost certain to get more NHS orders in the next few weeks. Good luck wherever you try and make your money back.

When you look at the increase in volume on Boursorama it makes you wonder whether someone has heard something...

Yes @Charliedog, the figures disclosed this morning are game changing.

£1m order / £5 a test = 200,000 tests
200k / 8 hospitals = 25k per hospital
25k / 4 weeks = 6250 per tests per week

All in line with realistic testing expectations. They provided just the right amount of information to calculate all this, truly outstanding opportunity for them to scale up from here. Even if 50 hospitals use them that would be £6.25m per month revenue from only 1 of 60 countries and with 2m capacity we can service this easily.

I’ll happily hold my hands up and admit my post on Saturday was wrong! Back in at 1.23, now that we know the financial value of the NHS orders the game has changed. Could go anywhere from here.